Brief: Dimerix Receives Initial Upfront Payment From FUSO
March 4 (Reuters) - Dimerix Ltd DXB.AX: RECEIVED UPFRONT PAYMENT OF ¥300 MILLION FROM FUSO PHARMACEUTICAL INDUSTRIES DIMERIX RECEIVES INITIAL UPFRONT PAYMENT FROM FUSO ANTICIPATES A FURTHER ¥400 MILLION FROM FUSO Further company coverage: DXB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions